Results 261 to 270 of about 621,791 (286)

Vaccine-boosted CAR T crosstalk with host immunity to reject tumors with antigen heterogeneity

Cell, 2023
Leyuan Ma, Wuhbet Abraham, Alexandra Neeser   +2 more
exaly  

A review of cancer immunotherapy toxicity

Ca-A Cancer Journal for Clinicians, 2020
Lucy Boyce Kennedy
exaly  

MR1 antigen presentation to MAIT cells and other MR1-restricted T cells

Nature Reviews Immunology, 2023
Jose A. Villadangos, Hamish E McWilliam
exaly  

83D4; antigen: Tn

Hybridoma, 1997
openaire   +1 more source

GPC2-CAR T cells tuned for low antigen density mediate potent activity against neuroblastoma without toxicity

Cancer Cell, 2022
Kevin R. Parker, Anya Alag, Crystal Mackall   +2 more
exaly  

Identifying and Targeting Human Tumor Antigens for T Cell-Based Immunotherapy of Solid Tumors

Cancer Cell, 2020
Vid Leko, Steven Rosenberg
exaly  

Prostate-specific antigen: Current status†

Ca-A Cancer Journal for Clinicians, 1999
Michael K Brawer, M K Brawer
exaly  

Prostate-specific antigen and premalignant change: Implications for early detection

Ca-A Cancer Journal for Clinicians, 1989
Michael K Brawer, M K Brawer, Paul H Lange   +2 more
exaly  

How to use prostate-specific antigen in the early detection orscreening for prostatic carcinoma

Ca-A Cancer Journal for Clinicians, 1995
Michael K Brawer, M K Brawer
exaly  

The use of cancer registry data to study preoperative carcinoembryonic antigen level as an indicator of survival in colorectal cancer

Ca-A Cancer Journal for Clinicians, 1989
Joan Chmiel, Joanne Sylvester
exaly